Imaging evaluation in the diagnosis and staging of malignant pleural mesothelioma

Seminars in Roentgenology

Volumn 39, Issue 3, 2004, Pages 386-396

  Truong, Mylene T ^a   Erasmus, Jeremy J ^a   Marom, Edith M ^a   Munden, Reginald F ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ASBESTOS;

ADJUVANT THERAPY; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; HUMAN; IMAGING SYSTEM; LUNG FUNCTION; MESOTHELIOMA; METASTASIS; MORBIDITY; MORTALITY; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; RADIOGRAPHY; REVIEW; THORAX RADIOGRAPHY;

EID: 3242723135     PISSN: 0037198X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ro.2004.04.005     Document Type: Article

References (33)

1. Connelly R.R., Spirtas R., Myers M.H., et al. Demographic patterns for mesothelioma in the United States. J Natl Cancer Inst. 78:1987;1053-1060
2. Walker A.M., Loughlin J.E., Friedlander E.R., et al. Projections of asbestos-related disease 1980-2009. J Occup Med. 25:1983;409-425
3. Pisani R.J., Colby T.V., Williams D.E. Malignant mesothelioma of the pleura. Mayo Clin Proc. 63:1988;1234-1244
4. McDonald A.D., McDonald J.C. Malignant mesothelioma in North America. Cancer. 46:1980;1650-1656
5. Ribak J., Lilis R., Suzuki Y., et al. Malignant mesothelioma in a cohort of asbestos insulation workers Clinical presentation, diagnosis, and causes of death. Br J Ind Med. 45:1988;182-187
6. Hodgson J.T., Darnton A. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg. 44:2000;565-601
7. Miller B.H., Rosado-de-Christenson M.L., Mason A.C., et al. From the archives of the AFIP. Malignant pleural mesothelioma Radiologic-pathologic correlation. Radiographics. 16:1996;613-644
8. Marom E.M., Erasmus J.J., Pass H.I., et al. The role of imaging in malignant pleural mesothelioma. Semin Oncol. 29:2002;26-35
9. Wang Z.J., Reddy G.P., Gotway M.B., et al. Malignant pleural mesothelioma Evaluation with CT, MR imaging, and PET. Radiographics. 24:2004;105-119
10. Wechsler R.J., Rao V.M., Steiner R.M. The radiology of thoracic malignant mesothelioma. Crit Rev Diagn Imaging. 20:1984;283-310
11. Leung A.N., Muller N.L., Miller R.R. CT in differential diagnosis of diffuse pleural disease. Am J Roentgenol. 154:1990;487-492
12. Kawashima A., Libshitz H.I. Malignant pleural mesothelioma CT manifestations in 50 cases. Am J Roentgenol. 155:1990;965-969
13. Patz E.F. Jr, Shaffer K., Piwnica-Worms D.R., et al. Malignant pleural mesothelioma value of CT and MR imaging in predicting resectability. Am J Roentgenol. 159:1992;961-966
14. Ng C.S., Munden R.F., Libshitz H.I. Malignant pleural mesothelioma the spectrum of manifestations on CT in 70 cases. Clin Radiol. 54:1999;415-421
15. Davis J.M. The pathology of asbestos related disease. Thorax. 39:1984;801-808
16. Rusch V.W., Godwin J.D., Shuman W.P. The role of computed tomography scanning in the initial assessment and the follow-up of malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 96:1988;171-177
17. Heelan R.T., Rusch V.W., Begg C.B., et al. Staging of malignant pleural mesothelioma Comparison of CT and MR imaging. Am J Roentgenol. 172:1999;1039-1047
18. Schouwink J.H., Kool L.S., Rutgers E.J., et al. The value of chest computer tomography and cervical mediastinoscopy in the preoperative assessment of patients with malignant pleural mesothelioma. Ann Thorac Surg. 75:2003;1715-1718. discussion 1718-1719
19. Sugarbaker D.J., Garcia J.P. Multimodality therapy for malignant pleural mesothelioma. Chest. 112:1997;272S-275S
20. Schneider D.B., Clary-Macy C., Challa S., et al. Positron emission tomography with f18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 120:2000;128-133
21. Ng D.C., Hain S.F., O'Doherty M.J., et al. Prognostic value of FDG PET imaging in malignant pleural mesothelioma. J Nucl Med. 41:2000;1443-1444
22. Benard F., Sterman D., Smith R.J., et al. Prognostic value of FDG PET imaging in malignant pleural mesothelioma. J Nucl Med. 40:1999;1241-1245
23. Antoch G., Stattaus J., Nemat A.T., et al. Non-small cell lung cancer dual-modality PET/CT in preoperative staging. Radiology. 229:2003;526-533
24. Lardinois D., Weder W., Hany T.F., et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med. 348:2003;2500-2507
25. Boutin C., Rey F., Gouvernet J., et al. Thoracoscopy in pleural malignant mesothelioma a prospective study of 188 consecutive patients. Part 2: prognosis and staging. Cancer. 72:1993;394-404
26. DiBonito L., Falconieri G., Colautti I., et al. Cytopathology of malignant mesothelioma a study of its patterns and histological bases. Diagn Cytopathol. 9:1993;25-31
27. Metintas M., Ozdemir N., Isiksoy S., et al. CT-guided pleural needle biopsy in the diagnosis of malignant mesothelioma. J Comput Assist Tomogr. 19:1995;370-374
28. Butchart E.G., Ashcroft T., Barnsley W.C., et al. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. Thorax. 31:1976;15-24
29. Sugarbaker D.J., Flores R.M., Jaklitsch M.T., et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma results in 183 patients. J Thorac Cardiovasc Surg. 117:1999;54-63. discussion 63-65
30. Rusch V.W. A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group. Chest. 108:1995;1122-1128
31. Patz E.F. Jr, Rusch V.W., Heelan R. The proposed new international TNM staging system for malignant pleural mesothelioma application to imaging. Am J Roentgenol. 166:1996;323-327
32. Tammilehto L., Kivisaari L., Salminen U.S., et al. Evaluation of the clinical TNM staging system for malignant pleural mesothelioma An assessment in 88 patients. Lung Cancer. 12:1995;25-34
33. Boutin C., Schlesser M., Frenay C., et al. Malignant pleural mesothelioma. Eur Respir J. 12:1998;972-981